Download Library

Date Document Type

ASCO 2014 <strong>Ipilimumab +- Dorgenmeltucel-L</strong>

ASCO 2014 <strong>Indoximod + Ipilimumuab</strong>

Ochsner Journal <strong>Combination Immunotherapy for High-Risk Resected ...</strong>

AACR 2014 <strong>IDO + PD1 Synergy</strong>

AACR 2014 <strong>TDO and IDO</strong>

AACR 2013 <strong>NLG919 and Indoximod</strong>

ESMO 2013 <strong>HyperAcute®</strong>

ASCO 2013 <strong>Algenpantucel-L</strong>

BioWorld Today <strong>NewLink's Phase II NSCLC Data Another Immunotherapy Boost</strong>

ASCO 2013 <strong>Ad.p53 DC Indoximod</strong>